High doses of radiation also in peripheral procedures

Original title: Patient radiation exposure during percutaneous endovascular revascularization of the lower extremity. Reference: Einat Segal et al. Journal of Vascular Surgery. Article in press.

Percutaneous endovascular revascularization is emerging as the first line treatment for peripheral artery disease for both intermittent claudication and chronic critical limb ischemia. Radiation doses for these interventions, usually prolonged, have not been well documented.

This retrospective study evaluated all lower extremity angioplasty procedures between 2006 and 2011 in a single center. Fluoroscopy time and dose area product (DAP) were registered. 382 procedures in 313 patients receiving lower extremity revascularization were included; a significantly higher DAP was observed in the primitive or the external iliac arteries compared to those performed in femoropopliteal (179.6 vs 63.2 Gy/cm2; p

The contraleteral access resulted in a in a higher DAP than the antegrade access (112.2 vs 42.6 Gy/cm2; p < 0.0001). In a multivariable analysis, the anatomical location of lesions presented the strongest association with radiation dose (p

Conclusion:

Revascularization procedures on lower extremities involve substantial radiation doses that can be compared, on average, with abdomen and pelvis CT scans. Pelvis procedures involve higher doses than those performed in femoropopliteal or infrapatellar territories.

 Editorial Comment:

Radiation doses should be taken into account especially in recanalization procedures of iliac arteries. For femoral or intrapatellar procedures, the antegrade access should be preferred whenever possible. Both the technical difficulty of puncture and the greater chance of complications should be counterbalanced with greater support, a stronger drive and now also lower radiation doses.

SOLACI.ORG

More articles by this author

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...

AHA/ACC Guideline on the Management of Acute Pulmonary Embolism 2026

The 2026 ACC/AHA guideline for the management of acute pulmonary embolism (PE) introduces a conceptual shift by replacing the traditional “risk-based” classification with an...

FFR Assessment for the Selection of Hypertensive Patients Who Benefit from Renal Stenting

Atherosclerotic renal artery stenosis (ARAS) represents one of the main causes of secondary hypertension (HTN) and is associated with a higher risk of renal...

Transcatheter Deep Vein Arterialization in Critical Limb Ischemia Without Revascularization Options

Chronic limb-threatening ischemia in patients without conventional revascularization options represents one of the most challenging scenarios within peripheral arterial disease, with 1-year major amputation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...